385 related articles for article (PubMed ID: 16598495)
1. Effect of pyridostigmine, pralidoxime and their combination on survival and cholinesterase activity in rats exposed to the organophosphate paraoxon.
Petroianu GA; Nurulain SM; Arafat K; Rajan S; Hasan MY
Arch Toxicol; 2006 Nov; 80(11):777-84. PubMed ID: 16598495
[TBL] [Abstract][Full Text] [Related]
2. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon.
Petroianu GA; Nurulain SM; Nagelkerke N; Al-Sultan MA; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(3):262-8. PubMed ID: 16583462
[TBL] [Abstract][Full Text] [Related]
3. In vivo metoclopramide protection of cholinesterase from paraoxon inhibition: direct comparison with pralidoxime in subchronic low-dose exposure.
Hasan MY; Nurulain SM; Arafat K; Naseer OP; Petroianu GA
J Appl Toxicol; 2004; 24(4):257-60. PubMed ID: 15300712
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine.
Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sheen R; Nagelkerke N
Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):235-40. PubMed ID: 17056080
[TBL] [Abstract][Full Text] [Related]
5. Protective agents in acute high-dose organophosphate exposure: comparison of ranitidine with pralidoxime in rats.
Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sha Ullah M; Naseer O
J Appl Toxicol; 2005; 25(1):68-73. PubMed ID: 15669039
[TBL] [Abstract][Full Text] [Related]
6. Tiapride pre-treatment in acute exposure to paraoxon: comparison of effects of administration at different points-in-time in rats.
Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Shafiullah M; Sheen R
Mol Cell Biochem; 2006 Apr; 285(1-2):79-86. PubMed ID: 16479322
[TBL] [Abstract][Full Text] [Related]
7. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
[TBL] [Abstract][Full Text] [Related]
8. Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon.
Petroianu GA; Nurulain SM; Nagelkerke N; Shafiullah M; Kassa J; Kuca K
J Appl Toxicol; 2007; 27(5):453-7. PubMed ID: 17304644
[TBL] [Abstract][Full Text] [Related]
9. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
Petroianu GA; Arafat K; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
[TBL] [Abstract][Full Text] [Related]
10. Effect of intrathecal pralidoxime administration upon survival of rats exposed to the organophosphate paraoxon.
Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Nagelkerke N; Petroianu GA
Neurotoxicology; 2008 Jul; 29(4):663-70. PubMed ID: 18457881
[TBL] [Abstract][Full Text] [Related]
11. Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine.
Petroianu GA; Hasan MY; Nurulain SM; Shafiullah M; Sheen R; Nagelkerke N
Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):312-6. PubMed ID: 17040217
[TBL] [Abstract][Full Text] [Related]
12. Metoclopramide protection of cholinesterase from paraoxon inhibition.
Petroianu GA; Hasan MY; Kosanovic M; Vijayasarathy C; Saleh AM
Vet Hum Toxicol; 2003 Oct; 45(5):251-3. PubMed ID: 14513894
[TBL] [Abstract][Full Text] [Related]
13. Protective drugs in acute large-dose exposure to organophosphates: a comparison of metoclopramide and tiapride with pralidoxime in rats.
Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sheen R; Saleh A; Schmitt A
Anesth Analg; 2005 Feb; 100(2):382-386. PubMed ID: 15673862
[TBL] [Abstract][Full Text] [Related]
14. Paraoxon has only a minimal effect on pralidoxime brain concentration in rats.
Petroianu GA; Lorke DE; Hasan MY; Adem A; Sheen R; Nurulain SM; Kalasz H
J Appl Toxicol; 2007; 27(4):350-7. PubMed ID: 17265425
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
16. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride.
Petroianu GA; Hasan MY; Arafat K; Nurulain SM; Schmitt A
J Appl Toxicol; 2005; 25(6):562-7. PubMed ID: 16193528
[TBL] [Abstract][Full Text] [Related]
17. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of ranitidine.
Petroianu GA; Arafat K; Schmitt A; Hasan MY
J Appl Toxicol; 2005; 25(1):60-7. PubMed ID: 15669026
[TBL] [Abstract][Full Text] [Related]
18. Intravenous pyruvic acid application in minipigs partially protects acetylcholine-esteratic but not butyrylcholine-esteratic activity in plasma from inhibition by paraoxon.
Petroianu GA; Ewald V; Thyes C; Missler A; Maleck WH
J Appl Toxicol; 2003; 23(1):37-42. PubMed ID: 12518335
[TBL] [Abstract][Full Text] [Related]
19. Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats.
Shaikh J; Karanth S; Chakraborty D; Pruett S; Pope CN
Arch Toxicol; 2003 Oct; 77(10):576-83. PubMed ID: 14574445
[TBL] [Abstract][Full Text] [Related]
20. In vitro protection of red blood cell acetylcholinesterase by metoclopramide from inhibition by organophosphates (paraoxon and mipafox).
Petroianu G; Arafat K; Kosanovic M; Saleh A; Camasamudram V; Hasan MY
J Appl Toxicol; 2003; 23(6):447-51. PubMed ID: 14635269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]